Molina Healthcare, Inc. MOH
1 target with a reported result
Releases of the last 3 yearsThe numbers MOH said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| Diluted EPS (company-defined) Fiscal 2026 |
Given at least $5.00 release Feb 5, 2026
Kept at least $5.00 release Apr 22, 2026
Raised at least $5.25 release Oct 21, 2026
|
– | No standard number | |
The company's wordsThe Company issued its full year 2026 earnings guidance with expected premium revenue of approximately $42 billion and adjusted earnings of at least $5.00 per diluted share. release Feb 5, 2026 The Company reaffirmed its full year 2026 guidance of expected premium revenue of approximately $42 billion and adjusted earnings of at least $5.00 per diluted share. release Apr 22, 2026 The Company reaffirmed its full year 2026 guidance of expected premium revenue of approximately $42 billion and adjusted earnings of at least $5.25 per diluted share. release Oct 21, 2026 | ||||
| Diluted EPS Fiscal 2026 |
Given at least $3.20 release Feb 5, 2026
Lowered at least $1.90 release Apr 22, 2026
Raised at least $2.38 release Oct 21, 2026
|
– | Not reported yet | |
The company's wordsThe Company expects its full year 2026 GAAP earnings to be at least $3.20 per diluted share and its full year 2026 adjusted earnings to be at least $5.00 per diluted share. release Feb 5, 2026 The Company expects its full year 2026 GAAP earnings to be at least $1.90 per diluted share and reaffirms its full year 2026 adjusted earnings of at least $5.00 per diluted share. release Apr 22, 2026 The Company expects its full year 2026 GAAP earnings to be at least $2.38 per diluted share and reaffirmed its full year 2026 adjusted earnings of at least $5.25 per diluted share. release Oct 21, 2026 | ||||
| Revenue Fiscal 2026 |
Given $42.00B release Jul 22, 2026
Kept $42.00B release Oct 21, 2026
|
– | Not reported yet | |
The company's wordsPremium revenue guidance for the full year is unchanged at approximately $42 billion. release Jul 22, 2026 Premium revenue guidance for the full year is unchanged at approximately $42 billion. release Oct 21, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Dec 31, 2025) |
Given at least $24.50 release Feb 5, 2025
Kept at least $24.50 release Apr 23, 2025
Changed $21.50 to $22.50 release Jul 7, 2025
Changed at least $19.00 release Jul 23, 2025
|
– | No standard number | |
The company's wordsThe Company issued its full year 2025 earnings guidance with expected premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share, which includes approximately $1.00 per diluted share of implementation costs for recent -MORE- Molina Healthcare, Inc. Reports Fourth Quarter and Year-End 2024 Financial Results release Feb 5, 2025 The Company reaffirmed its full year 2025 earnings guidance with expected premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share. release Apr 23, 2025 As a result, the Company now expects its full year 2025 adjusted earnings to be in the range of $21.50 to $22.50 per share, reflecting a consolidated pre-tax margin of just under 4%, the low-end of its long-term guidance range. release Jul 7, 2025 The Company now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share and reaffirms its premium revenue guidance of approximately $42 billion. release Jul 23, 2025 | ||||
| Revenue Fiscal 2025 (ended Dec 31, 2025) |
Given $42.50B release Oct 22, 2025
|
$45.43B 10-K filed 2026-02-10 |
Above the range | |
The company's wordsThe Company raised its premium revenue guidance to approximately $42.5 billion and now expects its full year 2025 adjusted earnings to be approximately $14.00 per diluted share. release Oct 22, 2025 | ||||
| Diluted EPS (company-defined) Q4 of fiscal 2025 |
Given $0.35 release Oct 22, 2025
|
– | No standard number | |
The company's wordsAs a result of the Company’s revised full year outlook, the implied fourth quarter 2025 adjusted earnings are expected to be approximately $0.35 per diluted share. release Oct 22, 2025 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Dec 31, 2024) |
Given at least $23.50 release Feb 7, 2024
Kept at least $23.50 release Apr 24, 2024
Kept at least $23.50 release Jul 24, 2024
Kept at least $23.50 release Oct 23, 2024
|
– | No standard number | |
The company's wordsThe Company issued its full year 2024 earnings guidance with expected premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share. -MORE- Molina Healthcare, Inc. Reports Fourth Quarter and Year-End 2023 Financial Results release Feb 7, 2024 The Company reaffirmed its full year 2024 guidance with expected premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share. -MORE- Molina Healthcare, Inc. Reports First Quarter 2024 Financial Results release Apr 24, 2024 The Company reaffirmed its full year 2024 guidance with expected premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share. -MORE- Molina Healthcare, Inc. Reports Second Quarter 2024 Financial Results release Jul 24, 2024 The Company reaffirmed its full year 2024 guidance with expected premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share. -MORE- Molina Healthcare, Inc. Reports Third Quarter 2024 Financial Results release Oct 23, 2024 | ||||
1 target far from the company's reported total, so not compared (usually a target for one product, segment or definition)
- Diluted EPS, Fiscal 2025 (ended Dec 31, 2025): said $11.90, reported $8.92. The company's words
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2024-02-07), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MOH/export.csv") into a cell.